Medtronic plc Insider Trading

MDT

Last 12 months

Insiders sold $14.7M and bought nothing on the open market.

41% of the selling was scheduled in advance under 10b5-1 plans. EVP & President Cardiovascular Harry Skip Kiil sold $5.13M on Feb 19, 62% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market

−$14.7M

0 buys · 7 sales

Under a 10b5-1 plan

41%

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

Aug 2025

Aug 25, 2025

Get an email when MDT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 15	Michael Marinaro EVP, Pres MedSurg and Americas	Sold10b5-1 plan	10,420	$96.00	$1M	9.0%	Form 4
Oct 15	Geoffrey Martha Chairman and CEO	Sold10b5-1 plan	50,000	$95.00	$4.75M	15%	Form 4
Sep 16	Harry Skip Kiil EVP & President Cardiovascular	SoldNo plan	1,483	$93.65	139K	3.4%	Form 4
Jul 8	Matthew R. Walter SVP, Chief HR Officer	Sold10b5-1 plan	3,102	$83.15	258K	8.0%	Form 4
Jun 8	Harry Skip Kiil EVP & President Cardiovascular	SoldNo plan 2 parts	4,189	$80.44 average	337K	10%	Form 4
Feb 19	Harry Skip Kiil EVP & President Cardiovascular	SoldNo plan 5 parts	52,524	$97.71 average	$5.13M	62%	Form 4
Nov 19, 2025	Gregory L Smith EVP Global Ops & Supply Chain	SoldNo plan 7 parts	30,000	$101.95 average	$3.06M	39%	Form 4
Sep 3, 2025	Harry Skip Kiil EVP & President Cardiovascular	SoldNo plan 2 parts	8,605	$91.58 average	788K	19%	Form 4
Aug 22, 2025 – Aug 25, 2025	William R Jellison Director	Bought 2 parts	5,000	$92.55 average	463K	New	Form 4
Jan 24, 2025	Brett A. Wall EVP & Pres Neuroscience	Sold10b5-1 plan	12,437	$90.00	$1.12M	23%	Form 4
Jan 8, 2025	Brett A. Wall EVP & Pres Neuroscience	Sold10b5-1 plan 2 parts	9,850	$80.41 average	792K	19%	Form 4

Oct 1510b5-1 plan
Michael Marinaro
EVP, Pres MedSurg and Americas · sold 10,420 at $96.00
$1M
9.0% of stake
Oct 1510b5-1 plan
Geoffrey Martha
Chairman and CEO · sold 50,000 at $95.00
$4.75M
15% of stake
Sep 16No plan
Harry Skip Kiil
EVP & President Cardiovascular · sold 1,483 at $93.65
139K
3.4% of stake
Jul 810b5-1 plan
Matthew R. Walter
SVP, Chief HR Officer · sold 3,102 at $83.15
258K
8.0% of stake
Jun 8No plan
Harry Skip Kiil
EVP & President Cardiovascular · sold 4,189 at avg $80.44
337K
10% of stake
Feb 19No plan
Harry Skip Kiil
EVP & President Cardiovascular · sold 52,524 at avg $97.71
$5.13M
62% of stake
Nov 19, 2025No plan
Gregory L Smith
EVP Global Ops & Supply Chain · sold 30,000 at avg $101.95
$3.06M
39% of stake
Sep 3, 2025No plan
Harry Skip Kiil
EVP & President Cardiovascular · sold 8,605 at avg $91.58
788K
19% of stake
Aug 22, 2025 – Aug 25, 2025
William R Jellison
Director · bought 5,000 at avg $92.55
463K
New position
Jan 24, 202510b5-1 plan
Brett A. Wall
EVP & Pres Neuroscience · sold 12,437 at $90.00
$1.12M
23% of stake
Jan 8, 202510b5-1 plan
Brett A. Wall
EVP & Pres Neuroscience · sold 9,850 at avg $80.41
792K
19% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MDT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with MDT

CompareIntrinsic value

MDLNMedline Inc.

$40.35+18.36%31

SYKStryker Corporation

$339.65+9.37%66

MMM3M Company

$193.99+9.57%46

BDXBecton, Dickinson and Company

$209.19+5.56%52

BSXBoston Scientific Corporation

$45.82+5.33%80

GEHCGE HealthCare Technologies Inc.

$85.81+6.38%46

BAXBaxter International Inc.

$26.50+3.96%32

ISRGIntuitive Surgical Inc.

$482.10+9.38%83

Held by ETFs

MDT is in 334 US ETFs. The largest of them, with MDT's weight in each:

Spot a number that looks wrong? Check it in MDT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MDT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.